Metonat solution for injections 100 mg/ml. 5 ml. ampoules №10

Description

Metonat composition                                                                                                                                                            active substance: methonate (3- (2,2,2-trimethylhydrazinium) propionate dihydrate);
5 ml of solution (1 ampoule) contain 500 mg of methonate (3- (2,2,2-trimethylhydrazinium) propionate dihydrate);
Excipient: water for injections.

Dosage form
Solution for injection.

Pharmacological properties
It is a remedy that improves metabolic processes in the heart muscle. In conditions of ischemia (insufficient blood supply), it restores the cellular balance between oxygen consumption and its delivery, prevents disruption of ATP transport, activates glycolysis without additional oxygen consumption. It helps to increase efficiency, reduce the severity of signs of physical and mental overstrain, activate immunity. Has a cardioprotective effect.
In case of acute ischemic myocardial injury, it reduces the area of ​​necrosis and shortens the rehabilitation period.

Indications
Metonat is used:

• with diseases of the heart, vascular system (chronic insufficiency, stable exertional angina, cardiomyopathy, functional disorders);
• with acute / chronic disorders of cerebral circulation;
• with reduced performance, psychoemotional or physical overstrain;
• recovery period after head injuries, cerebrovascular disorders, encephalitis.

Contraindications:

• with intolerance to the components of the drug;
• with increased intraocular pressure;
• with severe dysfunction of the liver, kidneys.

Application during pregnancy and lactation
Contraindicated.

Method of administration and dosage
Metonat solution is administered intravenously, preferably in the morning. Capsules – inside.

• The standard dose for adults with heart disease, vascular system – 500-1000 mg / day, maximum – 1000 mg / day.
• Standard doses for acute / chronic disorders of cerebral circulation – 500 mg / day, maximum – 500 mg / day.

The duration of therapy is 4-6 weeks with a frequency of 2-3 times a year.

Overdose
The drug is low toxic.
Possible symptoms: decreased blood pressure, tachycardia, dizziness, weakness.
Treatment is symptomatic. Monitoring of kidney and liver function is necessary.

Side effects:

• Urinary disorders: pollakiuria.
• Immune disorders: allergic dermatitis, urticaria, angioedema, anaphylactic reactions.
• Mental disorders: sleep disturbances, fear, agitation, obsessive thoughts.
• Neurological disorders: paresthesia, cephalalgia, tremor, vertigo, hypesthesia, tinnitus, gait disturbance, loss of consciousness.
• Cardiovascular disorders: palpitations, cardiac arrhythmias, tachycardia, discomfort in the region of the heart, atrial fibrillation, instability of blood pressure, hyperemia, pallor of the skin, hypertensive crisis.
• Respiratory disorders: pharyngitis, cough, apnea, dyspnea.
• Gastrointestinal disorders: dyspepsia, loss of appetite, dysgeusia (metallic taste in the mouth), nausea, diarrhea, flatulence, hypersalivation, dry mouth.
• Dermatological disorders: macular, papular eruptions, itching.
• Musculoskeletal disorders: back pain, myasthenia gravis, muscle spasms.
• General: weakness, asthenia, chills, swelling of the legs, face, cold sweat, hot or cold sensations.
• Laboratory changes: increased levels of C-reactive protein, dyslipidemia, abnormalities in the electrocardiogram, eosinophilia, tachycardia.

Storage conditions and periods
Store Metonat in its original packaging at a temperature not exceeding + 25 ° C. The maximum shelf life is 4 years from the date of production.